Newstral
Article
Fft.com on 2016-11-17 15:12
High stakes: Eli Lilly’s hunt for an Alzheimer’s drug
Related news
- FFT Magazine: High stakes: Eli Lilly’s hunt for an Alzheimer’s drugft.com
- FEli Lilly chief seeks to recover from Alzheimer’s drug flopft.com
- FEli Lilly & Co: US regulator delays decision on Eli Lilly’s Alzheimer’s drugft.com
- FPharmaceuticals: Alzheimer’s drug failure deals blow to US drugmaker Eli Lillyft.com
- FEli Lilly & Co: Eli Lilly’s Alzheimer’s drug wins backing of US advisory panelft.com
- What Is Donanemab? Eli Lilly’s Alzheimer’s Drug Gets Delayed Decision From FDAForbes
- FBiogen predicts preventive Alzheimer’s drugft.com
- ILilly’s Alzheimer’s drug setback is ‘not a thesis-breaker’invezz.com
- IEli Lilly Q2 results: its Alzheimer’s drug could be ‘the biggest drug in history’invezz.com
- FEli Lilly drops as Humalog drug sales disappointft.com
- FAxovant Alzheimer’s drug fails in clinical trialsft.com
- FEli Lilly raises Alzheimer’s drug hopesft.com
- Eli Lilly’s Experimental Alzheimer’s Drug Fails in Large TrialThe New York Times
- FDA Panel Unanimously Recommends Eli Lilly’s Alzheimer’s DrugForbes
- Eli Lilly’s promising Alzheimer’s drug fails in clinical trialsFOX 8 News Cleveland
- FLilly CEO seeks to recover from Alzheimer’s drug flopft.com
- FEli Lilly drops 14% after Alzheimer drug fails final stage trialft.com
- Eli Lilly’s new weight loss drug could drive down prices of Wegovy and OzempicDallas News
- FDA declines to give accelerated approval to Lilly’s Alzheimer’s drug, firm saysAlaska Dispatch News
- ICramer reacts to Eli Lilly’s telehealth service for weight-loss druginvezz.com